Seeking Alpha10d
Ascendis Pharma A/S (ASND) Q4 2024 Earnings Call Transcript
So the CNP question is always looking in the crystal ball. Because you asked ... This is a substitution of the long-acting effect, where you basically are placing part of the receptor system ...
Frontiers20d
Challenges to the Pair Bond: Neural and Hormonal Effects of Separation and Reunion in a Monogamous Primate
Males underwent a baseline scan, a short separation (48 h), a long separation (approximately ... respectively. Plasma insulin was measured in duplicate using commercial ELISA kits (Ultra Sensitive Rat ...
Interesting Engineering on MSN4d
FDA approves first-ever rapid-acting insulin biosimilar for diabetes treatment
The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.
Yahoo Finance8d
FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
SILVER SPRING, Md., Feb. 14, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement ...
Pharm Exec6d
FDA Approves Sanofi’s Rapid Acting Insulin Biosimilar Merilog for Diabetes
Merilog also marks the third insulin biosimilar approved in the United States, following two long-acting biosimilars approved in 2021. 1 "The FDA has now approved three biosimilar insulin products to ...
pharmaphorum2d
First biosimilar fast-acting insulin reaches US market
It is the first biosimilar of a rapid-acting insulin product – used to control the blood glucose spike after meals – and only the third insulin biosimilar to be approved in the US. Novo ...
Yahoo Finance8d
FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
SILVER SPRING, Md., Feb. 14, 2025 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of ...
WebMD2d
FDA OKs First Fast-Acting Insulin Biosimilar for Diabetes
Feb. 20, 2025 -- The FDA has approved a new fast-acting insulin biosimilar to help manage blood sugar in people with diabetes, including children and adults. The product, called Merilog ...
The Financial Express7d
FDA gives nod to first rapid-acting insulin biosimilar for diabetes treatment
Merilog is the third insulin biosimilar product approved by the FDA and joins the two long-acting insulin biosimilar products approved in 2021 by the FDA. Approval of biosimilar products can ...
Medscape5d
FDA Okays New Rapid-Acting Biosimilar Insulin for Diabetes
The FDA previously approved two long-acting insulin biosimilars, Mylan Pharmaceuticals’ Semglee in June 2020 and Lilly’s glargine biosimilar, Rezvoglar in December 2021. Merilog is approved as ...